1991
DOI: 10.2337/diab.40.12.1652
|View full text |Cite
|
Sign up to set email alerts
|

Effects of Chronic α-Adrenergic Receptor Blockade on Peripheral Nerve Conduction, Hypoxic Resistance, Polyols, Na+-K+-ATPase Activity, and Vascular Supply in STZ-D Rats

Abstract: The effects of alpha-receptor blockade on nerve conduction, hypoxic resistance, ouabain-sensitive Na(+)-K(+)-ATPase, nerve polyols, and capillary density were examined in streptozocin-induced diabetic (STZ-D) rats. Nondiabetic and untreated diabetic control groups were used. Diabetes duration was 2 mo. There were two treated diabetic groups. A "prevention" group received 5 mg/kg prazosin for 2 mo from the induction of diabetes. A "reversal" group was untreated for the 1st mo and was given prazosin for the subs… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

7
48
0

Year Published

1992
1992
2003
2003

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 75 publications
(55 citation statements)
references
References 31 publications
7
48
0
Order By: Relevance
“…However, whereas nerve Na ϩ ,K ϩ -ATPase activity is reduced in diabetic rats, there is little correlation between this defect and nerve dysfunction. For example, vasodilator treatment improved NCV without any effects on the Na ϩ ,K ϩ -ATPase deficit (37); protein kinase C inhibition also corrected NCV at doses that had no effect on Na ϩ ,K ϩ -ATPase, whereas higher doses corrected the Na ϩ ,K ϩ -ATPase deficit but had deleterious effects on NCV (38). Furthermore, low-dose acetyl carnitine prevented the Na ϩ ,K ϩ -ATPase defect but had no effect on NCV in diabetic rats (39).…”
Section: Discussionmentioning
confidence: 99%
“…However, whereas nerve Na ϩ ,K ϩ -ATPase activity is reduced in diabetic rats, there is little correlation between this defect and nerve dysfunction. For example, vasodilator treatment improved NCV without any effects on the Na ϩ ,K ϩ -ATPase deficit (37); protein kinase C inhibition also corrected NCV at doses that had no effect on Na ϩ ,K ϩ -ATPase, whereas higher doses corrected the Na ϩ ,K ϩ -ATPase deficit but had deleterious effects on NCV (38). Furthermore, low-dose acetyl carnitine prevented the Na ϩ ,K ϩ -ATPase defect but had no effect on NCV in diabetic rats (39).…”
Section: Discussionmentioning
confidence: 99%
“…Recently, several investigators have revealed vasa nervorum angiogenesis in diabetic rats following experiments using vasodilator therapy (15)(16)(17). The vasodilation induced by the increased generation of NO following ISDN treatment may induce angiogenesis of the vasa nervorum, and this may also explain the gradual increase in the analgesic effect of the spray by the end of the first week, which was sustained until treatment was discontinued.…”
Section: Study Design and Methodsmentioning
confidence: 99%
“…Nerve polyols nevertheless remain in the non-diabetic range, thus, a putative "pseudohypoxia" mechanism, based on changes in neuronal NADH/NAD ratio due to flux through the second half of the polyol pathway [41] is unlikely to cause the NCV reduction. Conversely, blood flow and NCV are restored by EPO and vasodilator treatments [2,4,5,19,39] although polyol pathway and pseudohypoxia mechanisms remain strongly activated. Thus, it must be concluded that pseudohypoxia does not contribute significantly to diabetic NCV changes and that neurovascular mechanisms predominate.…”
Section: Discussionmentioning
confidence: 99%
“…Taken together, these data suggest that a myo-inositol/Na-K ATPase mechanism is unlikely to contribute to the NCV or blood flow results. Furthermore, NCV deficits are corrected by vasodilator or EPO treatments that do not alter Na-K ATPase activity [32,39] and ARI/myo-inositol effects on Na-K ATPase are only found in rats fed a high sucrose diet [4O].…”
Section: Discussionmentioning
confidence: 99%